Table 1.

Classification and Examples of Products Identified by Horizon Scanning for the CDC Genomics and Health Impact Weekly Update showing translational phase groupings by product type.

	T0/T1 Discovery, characterization and development	T2 Evaluation of tests and interventions	T3/T4 Implementation in practice and programs
Original Studies (A)	GWAS, biomarkers, proposed new applications	clinical trials, clinical cohorts, new data on analytic or clinical validity	studies generating new process or outcome data from clinical populations, surveillance
Research Synthesis / Modeling / Meta Analysis/ Systematic reviews / Narrative reviews (B)	Meta analysis & systematic reviews of gene-disease associations	Evidence reports	cost-effectiveness analyses, national program evaluation
Guidelines / Policies / Recommendations (C)	new nomenclature, data sharing, publication standards	Clinical practice and professional guidelines	Electronic health standards, reporting requirements, ethical standards
Tools/ Methods / Training / Education / Decision Support (D)	research road maps, databases, software, training tools	modeling methods, databases, methods for systematic review	clinical algorithms, provider and patient education materials